Mont-Saint-Guibert, Belgium – Celyad (Euronext Brussels and Paris, and Nasdaq: CYAD), a clinical-stage biopharmaceutical company focused on the development of CAR-T cell-based therapies, today announced that management plans to participate at the following investor conferences in October and November 2019.
Conference details:
Investir Day 1st Edition
Date: Thursday, October 3, 2019
Presentation time: 12:45 p.m. CEDT
Location: Paris, France
CF&B Communication European Large & Midcap Event 19th Edition
Date: October 14-15, 2019
Location: Paris, France
Bryan, Garnier & Co European Healthcare Conference
Date: Wednesday, November 13, 2019
Location: Paris, France
Finance Avenue 2019
Date: Saturday, November 16, 2019
Presentation Time: 12:55 p.m. CEDT
Location: Brussels, Belgium
Jefferies 2019 London Healthcare Conference
Date: November 20 – 21, 2019
Location: London, United Kingdom
